Signaling Mechanisms Underlying Gastrointestinal Tract Tumorigenesis
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 1 August 2024 | Viewed by 78
Special Issue Editor
Interests: colorectal cancer; iron metabolism; hypoxia signaling; drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue seeks to comprehensively explore the current research landscape surrounding the intricate signaling mechanisms underlying tumorigenesis in the gastrointestinal tract. The gastrointestinal system plays a crucial role in various physiological processes, and understanding the aberrant signaling pathways leading to tumorigenesis is of paramount importance for developing effective diagnostic and therapeutic strategies.
Authors are invited to contribute original research, reviews and perspectives on diverse aspects of gastrointestinal tumorigenesis signaling. The Special Issue will encompass discussions on the latest findings, technological advancements and novel therapeutic targets related to signaling pathways implicated in the initiation, progression and metastasis of gastrointestinal tract tumors.
Therefore, the primary aim of this Special Issue is to consolidate knowledge on the molecular intricacies of gastrointestinal tumorigenesis, fostering a deeper understanding of the signaling events that drive cancer development in this vital organ system. By shedding light on these mechanisms, we aim to catalyze advancements in early detection, targeted therapies and personalized medicine for gastrointestinal cancers. Researchers, clinicians and experts in the field are encouraged to contribute their insights to collectively advance our understanding and impact the future of gastrointestinal cancer research and treatment.
Dr. Xiang Xue
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell signaling
- GI
- cancer
- initiation
- progression
- metastasis
- early detection
- targeted therapies
- personalized medicine
